Sumitoma Pharma US
Amy Farrell is a seasoned professional in the pharmaceutical industry, currently serving as a Senior Multi-Specialty Portfolio Specialist at Sumitomo Pharma America, Inc., since July 2023, where recognition includes Circle of Excellence awards for 2023 and 2024. Prior experience includes the role of Women’s Health Account Manager at Myovant Sciences, contributing to the launch of Myfembree for the treatment of endometriosis and uterine fibroids. At Amgen, Farrell excelled as a Senior Biopharmaceutical Representative, promoting Enbrel and Prolia. Previous roles include Women's Health Specialist at Myriad Genetics, where significant territory growth was achieved, Sales Representative at PDI Incorporated, and Territory Representative at Wyeth Pharmaceuticals. Farrell holds a BA in Communications from the State University of New York at Oswego.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.